Buy Day today: Neutral (53) Mixed market breadth · no major macro event

ANI Pharmaceuticals Inc (ANIP)

Healthcare Drug Manufacturers - Specialty & Generic

79.20 $

-1.5% vs. previous close

Closing price · As of: 31. Jul 2026

ANI Pharmaceuticals Inc (ANIP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 1,422 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet ANIP
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	859	890	904	915	921	1,287	1,284	1,292	1,343	1,408	1,440	1,422
Current Assets	459	497	520	541	555	521	528	536	603	698	753	747
Cash	162	193	221	229	240	145	145	150	218	263	286	311
Cash & Short-Term Investments	162	193	221	238	247	153	151	155	224	263	286	311
Receivables	173	179	162	172	166	196	222	220	226	253	281	255
Inventory	104	107	111	114	125	148	137	137	138	146	143	143
Property, Plant & Equipment	44	–	–	–	–	–	–	–	–	–	–	–
Goodwill	28	28	28	28	28	60	60	61	61	62	62	62
Intangible Assets	230	220	209	196	183	570	542	538	520	500	480	467
Total Liabilities	425	435	472	463	440	857	855	849	881	902	900	860
Current Liabilities	123	134	145	137	140	190	194	202	237	271	278	240
Short-Term Debt	0.9	0.9	0.9	0.9	0.9	7.2	9.2	11	13	15	17	19
Accounts Payable	29	34	37	49	49	61	46	53	55	70	63	70
Long-Term Debt	285	285	285	285	284	618	615	612	608	605	600	594
Shareholders' Equity	434	455	433	452	481	431	429	443	462	506	541	562
Retained Earnings	-90	-81	-80	-62	-65	-90	-100	-85	-77	-51	-23	6.4
Shares Outstanding	18	19	19	19	19	19	19	20	20	21	21	22

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings